<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are severe late complications of treatment with genotoxic chemotherapeutic agents </plain></SENT>
<SENT sid="1" pm="."><plain>Children with <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> type 1 (NF1) are predisposed to malignant myeloid disorders that are associated with inactivation of the NF1 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in the leukemic clone </plain></SENT>
<SENT sid="2" pm="."><plain>Recent clinical data suggest that NF1 might be also associated with an increased risk of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> after treatment with alkyating agents </plain></SENT>
<SENT sid="3" pm="."><plain>To test this hypothesis, we administered <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> or <z:chebi fb="0" ids="4911">etoposide</z:chebi> to cohorts of <z:mp ids='MP_0002169'>wild-type</z:mp> and heterozygous Nf1 knockout mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> exposure cooperated strongly with heterozygous inactivation of Nf1 in myeloid <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e>, while <z:chebi fb="0" ids="4911">etoposide</z:chebi> did not </plain></SENT>
<SENT sid="5" pm="."><plain>Somatic loss of the <z:mpath ids='MPATH_458'>normal</z:mpath> Nf1 allele correlated with clinical disease and was more common in 129/Sv mice than in 129/Sv x C57BL/6 animals </plain></SENT>
<SENT sid="6" pm="."><plain>Leukemic cells showing loss of heterozygosity at Nf1 retained a structural allele on each chromosome 11 homolog </plain></SENT>
<SENT sid="7" pm="."><plain>These studies establish a novel in vivo model of alkylator-induced <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancy</z:e> that will facilitate mechanistic and translational studies </plain></SENT>
</text></document>